GMP production of active pharmaceutical ingredients

BIOMEVA's facility is dedicated to the large-scale manufacturing of APIs expressed in microbial systems. Recombinant material on a clinical and commercial scale can be produced in batches up to 1000 L working volume.


Production and purification systems include:

  • Fermenters with working volumes of 10 L, 100 L and 1000 L
  • Continuous centrifugation
  • High-pressure homogenization
  • Protein micro-filtration and ultra-filtration
  • Sterile filtration
  • Column chromatography
  • Bulk drug substance filling